Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 36 Records) |
Query Trace: Leukemia and CR1[original query] |
---|
Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations. Annals of oncology : official journal of the European Society for Medical Oncology 2017 9 28 (11): 2793-2798. Heidrich K, Thiede C, Schäfer-Eckart K, Schmitz N, Aulitzky W E, Krämer A, Rösler W, Hänel M, Einsele H, Baldus C D, Trappe R U, Stölzel F, Middeke J M, Röllig C, Taube F, Kramer M, Serve H, Berdel W E, Ehninger G, Bornhäuser M, Schetelig J, |
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT. American journal of hematology 2018 4 93 (7): 859-866. Gorin Norbert Claude, Labopin Myriam, Blaise Didier, Dumas Pierre-Yves, Pabst Thomas, Trisolini Silvia Maria, Arcese William, Houhou Mohamed, Mohty Mohamad, Nagler Arn |
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission. American journal of hematology 2018 11 94 (2): 231-239. Poiré Xavier, Labopin Myriam, Polge Emmanuelle, Blaise Didier, Chevallier Patrice, Maertens Johan, Deconinck Eric, Forcade Edouard, Rambaldi Alessandro, Baerlocher Gabriela M, Zuckerman Tsila, Volin Liisa, Schouten Harry C, Ifrah Norbert, Mohty Mohamad, Esteve Jordi, Nagler Arn |
Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia. Blood advances 2018 10 2 (20): 2744-2754. Sakaguchi Masahiro, Yamaguchi Hiroki, Najima Yuho, Usuki Kensuke, Ueki Toshimitsu, Oh Iekuni, Mori Sinichiro, Kawata Eri, Uoshima Nobuhiko, Kobayashi Yutaka, Kako Shinichi, Tajika Kenji, Gomi Seiji, Shono Katsuhiro, Kayamori Kensuke, Hagihara Masao, Kanda Junya, Uchiyama Hitoji, Kuroda Junya, Uchida Naoyuki, Kubota Yasushi, Kimura Shinya, Kurosawa Saiko, Nakajima Nana, Marumo Atsushi, Omori Ikuko, Fujiwara Yusuke, Yui Shunsuke, Wakita Satoshi, Arai Kunihito, Kitano Tomoaki, Kakihana Kazuhiko, Kanda Yoshinobu, Ohashi Kazuteru, Fukuda Takahiro, Inokuchi Koi |
Pattern and prognostic value of FLT3-ITD mutations in Chinese de novo adult acute myeloid leukemia. Cancer science 2018 Dec 109 (12): 3981-3992. Liu Song-Bai, Qiu Qiao-Cheng, Bao Xie-Bing, Ma Xiao, Li Hong-Zhi, Liu Yue-Jun, Chen Su-Ning, Song Yao-Hua, Wu De-Pei, Xue Sheng- |
Genomic CDKN2A/2B deletions in adult Ph ALL are adverse despite allogeneic stem cell transplantation. Blood 2018 Jan . Pfeifer Heike, Raum Katharina, Markovic Sandra, Nowak Verena, Fey Stephanie, Obländer Julia, Pressler Jovita, Böhm Verena, Brüggemann Monika, Wunderle Lydia, Hüttmann Andreas, Wäsch Ralph, Beck Joachim, Stelljes Matthias, Viardot Andreas, Lang Fabian, Hoelzer Dieter, Hofmann Wolf-Karsten, Serve Hubert, Weiss Christel, Goekbuget Nicola, Ottmann Oliver G, Nowak Dani |
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1. Blood cancer journal 2018 Jan 8 (1): 4. Saygin Caner, Hirsch Cassandra, Przychodzen Bartlomiej, Sekeres Mikkael A, Hamilton Betty K, Kalaycio Matt, Carraway Hetty E, Gerds Aaron T, Mukherjee Sudipto, Nazha Aziz, Sobecks Ronald, Goebel Christopher, Abounader Donna, Maciejewski Jaroslaw P, Advani Anjali |
Unmanipulated haploidentical peripheral blood stem cell transplantation for patients with Philadelphia-negative acute lymphoblastic leukaemia in first complete remission. Leukemia & lymphoma 2019 9 61 (1): 118-127. Wang Feiyan, Liu Tong, Wang Li, Gu Zhenyang, Yang Nan, Luo Lan, Zhu Chengying, Li Meng, Liu Daihong, Gao Chun |
Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis. Cancer management and research 2019 6 11 4129-4142. Huang Yan, Hu Juan, Lu Ting, Luo Yi, Shi Jimin, Wu Wenjun, Han Xiaoyan, Zheng Weiyan, He Jingsong, Cai Zhen, Wei Guoqing, Huang He, Sun J |
High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia. American journal of hematology 2019 6 94 (8): 921-928. Patel Sanjay S, Pinkus Geraldine S, Ritterhouse Lauren L, Segal Jeremy P, Dal Cin Paola, Restrepo Tamara, Harris Marian H, Stone Richard M, Hasserjian Robert P, Weinberg Olga |
Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome. Clinical lymphoma, myeloma & leukemia 2019 5 19 (7): 462-469. Jindra Pavel, Raida Lud?k, Karas Michal, Szotkowski Tomáš, Lysák Daniel, Hrab?tová Marcela, Jungová Alexandra, Steinerová Kate?ina, Faber Edgar, Papajík Tom |
[Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Treatment of Intermediate Risk Acute Myeloid Leukemia with Negative for FLT3-ITD, NPM1 or Biallelic CEBPA Mutation]. Zhongguo shi yan xue ye xue za zhi 2020 6 28 (3): 731-736. Chen Chun, Qi Jia-Qian, Chu Tian-Tian, Wang Hong, Wu De-Pei, Ruan Chang-Geng, Han Y |
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission. Bone marrow transplantation 2020 May . Shouval Roni, Labopin Myriam, Bomze David, Baerlocher Gabriela M, Capria Saveria, Blaise Didier, Hänel Mathias, Forcade Edouard, Huynh Anne, Saccardi Riccardo, Milone Giuseppe, Zuckerman Tsila, Reményi Péter, Versluis Jurjen, Esteve Jordi, Gorin Norbert Claude, Mohty Mohamad, Nagler Arn |
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation. Annals of hematology 2020 Apr . Helbig Grzegorz, Kocl?ga Anna, Wieczorkiewicz-Kabut Agata, Wo?niczka Krzysztof, Kopi?ska Anna, Boral Kinga, Grygoruk-Wi?niowska Iwona, Stachowicz Ma?gorzata, Karolczyk Agniesz |
Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation 2020 11 56 (5): 1047-1055. Giebel Sebastian, Labopin Myriam, Socié Gerard, Beauvais David, Klein Stefan, Wagner-Drouet Eva Maria, Blaise Didier, Nguyen-Quoc Stephanie, Bourhis Jean Henri, Thiebaut Anne, Labussière-Wallet Hélène, Charbonnier Amandine, Berceanu Ana, Diez-Martin José Luis, Fegueux Nathalie, Esteve Jordi, Nagler Arnon, Mohty Moham |
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT. Journal of hematology & oncology 2021 5 14 (1): 84. Sanz Jaime, Galimard Jacques-Emmanuel, Labopin Myriam, Afanasyev Boris, Sergeevich Moiseev Ivan, Angelucci Emanuele, Kröger Nicolaus, Koc Yener, Ciceri Fabio, Diez-Martin J L, Arat Mutlu, Sica Simona, Rovira Montserrat, Aljurf Mahmoud, Tischer Johanna, Savani Bipin, Ruggeri Annalisa, Nagler Arnon, Mohty Moham |
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study. Blood 2021 4 137 (20): 2827-2837. Duchmann Matthieu, Micol Jean-Baptiste, Duployez Nicolas, Raffoux Emmanuel, Thomas Xavier, Marolleau Jean-Pierre, Braun Thorsten, Adès Lionel, Chantepie Sylvain, Lemasle Emilie, Berthon Céline, Malfuson Jean-Valère, Pautas Cécile, Lambert Juliette, Boissel Nicolas, Celli-Lebras Karine, Caillot Denis, Turlure Pascal, Vey Norbert, Pigneux Arnaud, Recher Christian, Terré Christine, Gardin Claude, Itzykson Raphaël, Preudhomme Claude, Dombret Hervé, de Botton Stépha |
The clinical characteristics and prognosis of Chinese acute myeloid leukemia patients with CSF3R mutations. International journal of laboratory hematology 2021 Nov . Chen Xiuhua, Xu Jing, Fang Fang, Xu Zhifang, Tan Yanhong, Chang JianMei, Muyey Daniel Muteb, Wang Hongw |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission. Bone marrow transplantation 2021 10 57 (1): 95-105. Tien Feng-Ming, Tsai Cheng-Hong, Huang Sheng-Chuan, Liu Jia-Hau, Chen Chien-Yuan, Kuo Yuan-Yeh, Chuang Yi-Kuang, Tseng Mei-Hsuan, Peng Yen-Ling, Liu Ming-Chih, Liu Chia-Wen, Liao Xiu-Wen, Lin Liang-In, Wu Yu-Sin, Hou Mei-Fang, Wu Shang-Ju, Hsu Szu-Chun, Ko Bor-Sheng, Chou Wen-Chien, Yao Ming, Hou Hsin-An, Tang Jih-Luh, Tien Hwei-Fa |
Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study. Clinical hematology international 2021 10 1 (1): 58-74. Bazarbachi Ali, Labopin Myriam, Battipaglia Giorgia, Djabali Azedine, Forcade Edouard, Arcese William, Socié Gerard, Blaise Didier, Halter Joerg, Gerull Sabine, Cornelissen Jan J, Chevallier Patrice, Maertens Johan, Schaap Nicolaas, El-Cheikh Jean, Esteve Jordi, Nagler Arnon, Mohty Moham |
The Clinical Outcomes and Genomic Landscapes of Acute Lymphoblastic Leukemia Patients with E2A-PBX1: A 10-year Retrospective Study. American journal of hematology 2021 Aug . Zhou Biqi, Chu Xinran, Tian Hong, Liu Tianhui, Liu Hong, Gao Wei, Chen Suning, Hu Shaoyan, Wu Depei, Xu Ya |
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation. Journal of hematology & oncology 2022 09 15 (1): 126. Kunadt Desiree, Stasik Sebastian, Metzeler Klaus H, Röllig Christoph, Schliemann Christoph, Greif Philipp A, Spiekermann Karsten, Rothenberg-Thurley Maja, Krug Utz, Braess Jan, Krämer Alwin, Hochhaus Andreas, Scholl Sebastian, Hilgendorf Inken, Brümmendorf Tim H, Jost Edgar, Steffen Björn, Bug Gesine, Einsele Hermann, Görlich Dennis, Sauerland Cristina, Schäfer-Eckart Kerstin, Krause Stefan W, Hänel Mathias, Hanoun Maher, Kaufmann Martin, Wörmann Bernhard, Kramer Michael, Sockel Katja, Egger-Heidrich Katharina, Herold Tobias, Ehninger Gerhard, Burchert Andreas, Platzbecker Uwe, Berdel Wolfgang E, Müller-Tidow Carsten, Hiddemann Wolfgang, Serve Hubert, Stelljes Matthias, Baldus Claudia D, Neubauer Andreas, Schetelig Johannes, Thiede Christian, Bornhäuser Martin, Middeke Jan M, Stölzel Friedrich, |
The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China. Frontiers in oncology 2022 12 846573. Xiao Jinyan, Cai Zihong, Wang Hao, Li Xuekai, Zhou Biqi, Liu Yujie, Wang Ying, Xu Peipei, Wang Li, Wu Depei, Dou Liping, Zhou Hongsheng, Xu Ya |
Cytogenetic abnormalities in NPM1-mutated acute myeloid leukemia. Leukemia & lymphoma 2022 3 63 (8): 1956-1963. Fu Weijia, Huang Aijie, Xu Lili, Peng Yanni, Gao Lei, Chen Li, Chen Jie, Tang Gusheng, Yang Jianmin, Ni Xio |
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. American journal of hematology 2022 1 97 (3): 329-337. Reville Patrick K, Sasaki Koji, Kantarjian Hagop M, Daver Naval G, Yilmaz Musa, Dinardo Courtney D, Short Nicholas J, Borthakur Gautam, Pemmaraju Naveen, Mehta Rohtesh S, Pierce Sherry, Konoplev Sergej N, Khoury Joseph D, Garcia-Manero Guillermo, Konopleva Marina Y, Jabbour Elias, Ravandi Farhad, Kadia Tapan |
Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia. Cancer medicine 2022 Feb 11 (4): 1068-1080. Al Hamed Rama, Labopin Myriam, Daguindau Etienne, Niittyvuopio Riitta, Huynh Anne, Socié Gerard, Srour Micha, Henri Bourhis Jean, Kröger Nicolaus, Tholouli Eleni, Choi Goda, Poiré Xavier, Martin Hans, Rubio Marie-Thérèse, Jindra Pavel, Blaise Didier, Beelen Dietrich, Labussière-Wallet Hélène, Nagler Arnon, Bazarbachi Ali, Mohty Moham |
TCR??/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis. Blood 2023 9 . Pietro Merli, Mattia Algeri, Federica Galaverna, Valentina Bertaina, Barbarella Lucarelli, Emilia Boccieri, Marco Becilli, Francesco Quagliarella, Chiara Rosignoli, Simone Biagini, Elia Girolami, Antonella Meschini, Giovanna Del Principe, Raffaella Sborgia, Maria Luigia Catanoso, Roberto Carta, Luisa Strocchio, Rita Maria Pinto, Barbara Buldini, Michela Falco, Raffaella Meazza, Daniela Pende, Marco Andreani, Giuseppina Li Pira, Daria Pagliara, Franco Locatel |
Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia. medRxiv : the preprint server for health sciences 2023 8 . Gege Gui, Laura W Dillon, Niveditha Ravindra, Pranay S Hegde, Georgia Andrew, Devdeep Mukherjee, Zoë Wong, Jeffery Auletta, Firas El Chaer, Evan Chen, Yi-Bin Chen, Adam Corner, Steven M Devine, Sunil Iyer, Antonio Martin Jimenez Jimenez, Marcos J G De Lima, Mark R Litzow, Partow Kebriaei, Stephen R Spellman, Scott L Zeger, Kristin M Page, Christopher S Hourig |
The FLT3-ITD allelic ratio and NPM1 mutation do not impact outcomes in AML patients with FLT3-ITD after allo-HSCT: a retrospective propensity-score matching study. Transplantation and cellular therapy 2023 4 . Zhou Cuiyan, Zheng Fengmei, Xu Lanping, Zhang Xiaohui, Chang Yingjun, Mo Xiaodong, Sun Yuqian, Huang Xiaojun, Wang |
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors. Cell transplantation 2024 1 33 9636897231225821. Bingqian Jiang, Yanmin Zhao, Yi Luo, Jian Yu, Yi Chen, Baodong Ye, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Yishan Ye, Weiyan Zheng, Jie Sun, Jingsong He, Yi Zhao, Guoqing Wei, Zhen Cai, He Huang, Jimin S |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: